‘Hardest deal is always the first one’ — Partnership adapts Motega Health tech for animal use
January 25, 2019 | Austin Barnes
A new licensing deal with Simini Technologies has unleashed disruptive potential for Lawrence-built Motega Health, the company announced Thursday.
“We are very pleased to be partnering with Simini and their team and are excited by the energy and creative thinking they are bringing to the commercial process in veterinary medicine,” said Dr. Blake Hawley, founder and CEO of Motega Health –– a biopharmaceutical and food tech company.
“The hardest deal is always the first one, just like getting that first investor. As we demonstrate traction, we show value. We increase our revenue and our long term value skyrockets –– something every investor wants,” Hawley said of the partnership, which marks the company’s first major pharmaceutical pairing –– a connection made possible through St. Louis’ Shear Kershman Laboratories, he added.
As part of the agreement, Motega Health will provide Simini Technologies –– a pharmaceutical company that licenses veterinary rights to human health drug candidates and then develops products for use in animals –– with a license that allows them to research, develop, and commercialize Motega Health’s novel therapies for animals, he said.
Simini Technologies will also assume any further research opportunities and commercial activities, Hawley further explained of the partnership.
“Long term investment allows us to dramatically accelerate our studies and market our products for licensing,” Hawley said of the opportunity to work with Simini Technologies during the early stage phase of Motega Health –– founded in 2018.
Read more about Motega Health in the news here.
“We have been able to demonstrate oral mucosal absorption with drugs and compounds previously thought impossible,” Hawley said in explanation of what drew the company’s together. “This is ground-breaking and has literally hundreds of applications.”
Disrupting the health space one innovation at a time, Motega Health is enabling drug companies to eliminate injections, pills, and tablets. A process that could align the company for exponential growth, Hawley said.
Such growth could include significant investments in the company from Kansas City investors, Hawley revealed.
“We just started our cap raise in November and have had some recent great meetings in KC, which have led to more meetings and warm introductions [with potential investors.]”
Between the company’s deal with Simini Technologies and the potential weight of a first round capital raise, Hawley is eager to see how Motega Health can evolve in the startup space, he said.
Featured Business
2019 Startups to Watch
stats here
Related Posts on Startland News
OneHQ launches hiring spree for anticipated growth
OneHQ, formerly NexusHQ, is beefing up its staff in anticipation of a projected revenue boom. The insurance and finance software company plans to add 13 employees — bringing its total headcount to 20 — in the next year as it anticipates more than doubling its annual revenue. The company reported revenue of more than $1 million…
Former Kauffman Foundation VP on how to scale via networking
With more than 25 years of leadership experience, Lesa Mitchell knows a thing or two about making — and fostering — valuable connections. Previously the vice president of innovation at the Ewing Marion Kauffman Foundation and a former executive at Marion Labs, Mitchell now is the founder of Networks for Scale, a company that works…
Windhaven Farms, Chemistry take 1 Million Cups stage
The seemingly disparate industries of agriculture and marketing were on display this week at 1 Million Cups with startups Windhaven Farms and Chemistry. Windhaven Farms founder Kristen Wolf first presented her local meat distribution company, which delivers an assortment of locally-raised, organically-grown meat products, including beef, pork, chicken and rabbit. “The product is really, really…